This company has been marked as potentially delisted and may not be actively trading. Symmetry Medical (SMA) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsInsider TradesTrendsBuy This Stock SMA vs. ABT, ISRG, BSX, SYK, MDT, BDX, EW, IDXX, RMD, and DXCMShould you be buying Symmetry Medical stock or one of its competitors? The main competitors of Symmetry Medical include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "health care equipment" industry. Symmetry Medical vs. Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom Abbott Laboratories (NYSE:ABT) and Symmetry Medical (NYSE:SMA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability. Does the media refer more to ABT or SMA? In the previous week, Abbott Laboratories had 42 more articles in the media than Symmetry Medical. MarketBeat recorded 43 mentions for Abbott Laboratories and 1 mentions for Symmetry Medical. Abbott Laboratories' average media sentiment score of 1.23 beat Symmetry Medical's score of 0.00 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 31 Very Positive mention(s) 4 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Symmetry Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate ABT or SMA? Abbott Laboratories currently has a consensus target price of $142.59, suggesting a potential upside of 7.60%. Symmetry Medical has a consensus target price of $38.30, suggesting a potential upside of 8.13%. Given Symmetry Medical's stronger consensus rating and higher possible upside, analysts plainly believe Symmetry Medical is more favorable than Abbott Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 1 Strong Buy rating(s) 2.84Symmetry Medical 0 Sell rating(s) 0 Hold rating(s) 9 Buy rating(s) 3 Strong Buy rating(s) 3.25 Which has stronger earnings & valuation, ABT or SMA? Abbott Laboratories has higher revenue and earnings than Symmetry Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$42.34B5.44$13.40B$7.7117.19Symmetry MedicalN/AN/AN/AN/AN/A Does the MarketBeat Community prefer ABT or SMA? Abbott Laboratories received 816 more outperform votes than Symmetry Medical when rated by MarketBeat users. However, 82.42% of users gave Symmetry Medical an outperform vote while only 70.00% of users gave Abbott Laboratories an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes95270.00% Underperform Votes40830.00% Symmetry MedicalOutperform Votes13682.42% Underperform Votes2917.58% Do institutionals & insiders have more ownership in ABT or SMA? 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is ABT or SMA more profitable? Abbott Laboratories has a net margin of 31.95% compared to Symmetry Medical's net margin of 0.00%. Abbott Laboratories' return on equity of 20.74% beat Symmetry Medical's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories31.95% 20.74% 11.19% Symmetry Medical N/A N/A N/A SummaryAbbott Laboratories beats Symmetry Medical on 10 of the 14 factors compared between the two stocks. Get Symmetry Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for SMA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMA vs. The Competition Export to ExcelMetricSymmetry Medical Industry SectorNYSE ExchangeMarket CapN/A$2.70B$2.45B$19.12BDividend YieldN/A13.11%13.12%3.95%P/E RatioN/A11.2310.9533.42Price / SalesN/A2,154,409.403,466,149.6928.34Price / CashN/A17.2759.3917.52Price / BookN/A3.153.444.53Net IncomeN/A$38.79M-$340.43M$1.02B Symmetry Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMASymmetry MedicalN/A$35.42-1.1%$38.30+8.1%N/A$0.00N/A0.00N/AHigh Trading VolumeABTAbbott Laboratories4.8981 of 5 stars$130.71+0.2%$142.59+9.1%+25.1%$226.33B$41.95B17.09115,000Positive NewsISRGIntuitive Surgical4.6824 of 5 stars$515.80+0.2%$598.95+16.1%+39.5%$184.87B$8.71B80.4712,100Positive NewsBSXBoston Scientific4.1077 of 5 stars$102.90+0.2%$114.52+11.3%+43.1%$152.20B$17.55B82.3245,000Insider TradePositive NewsSYKStryker4.8135 of 5 stars$374.06+0.8%$424.56+13.5%+16.1%$142.77B$22.60B48.2051,000Earnings ReportAnalyst ForecastAnalyst RevisionMDTMedtronic4.4936 of 5 stars$84.60flat$96.14+13.6%+2.1%$108.50B$33.20B25.7195,000Positive NewsBDXBecton, Dickinson and Company4.9378 of 5 stars$206.89+0.2%$272.86+31.9%-28.9%$59.41B$20.64B34.3777,000Earnings ReportDividend AnnouncementEWEdwards Lifesciences4.5596 of 5 stars$75.50-1.0%$79.45+5.2%-11.8%$44.38B$5.25B10.8317,300Positive NewsIDXXIDEXX Laboratories4.4906 of 5 stars$432.65-1.0%$523.75+21.1%-1.2%$35.06B$3.90B40.5510,800Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsHigh Trading VolumeRMDResMed4.0493 of 5 stars$236.49-0.5%$258.83+9.4%+10.9%$34.73B$5.02B27.928,160Analyst UpgradePositive NewsDXCMDexCom4.7048 of 5 stars$71.38+0.1%$99.00+38.7%-37.5%$27.99B$4.03B49.927,600Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies Abbott Laboratories Alternatives Intuitive Surgical Alternatives Boston Scientific Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SMA) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Symmetry Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Symmetry Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMA Stock Free SMA Stock Alerts